Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2002
11/07/2002WO2002088734A1 System for measuring membrane permeation
11/07/2002WO2002088733A1 Analysis method using reporter (label) intermolecular interaction
11/07/2002WO2002088732A1 Improved qualitative and/or quantitative immunoassay method by immunoblot, kit and device therefor
11/07/2002WO2002088731A2 Biopolymer marker having a molecular weight of 1211 daltons
11/07/2002WO2002088730A2 Biopolymer marker having a molecular weight of 1525 daltons
11/07/2002WO2002088729A2 Biopolymer marker having a molecular weight of 1562 daltons
11/07/2002WO2002088728A2 Biopolymer marker having a molecular weight of 1020 daltons
11/07/2002WO2002088727A2 Biopolymer marker having a molecular weight of 1690 daltons
11/07/2002WO2002088726A2 Biopolymer marker having a molecular weight of 1449 daltons
11/07/2002WO2002088725A2 Biopolymer marker having a molecular weight of 1793 daltons
11/07/2002WO2002088724A2 Biopolymer marker having a molecular weight of 1896 daltons
11/07/2002WO2002088723A2 Biopolymer marker having a molecular weight of 1406 daltons
11/07/2002WO2002088722A2 Biopolymer marker having a molecular weight of 1350 daltons
11/07/2002WO2002088721A2 Biopolymer marker having a molecular weight of 1206 daltons
11/07/2002WO2002088720A2 Biopolymer marker having a molecular weight of 1348 daltons
11/07/2002WO2002088719A2 Biopolymer marker having a molecular weight of 1424 daltons
11/07/2002WO2002088718A2 Biopolymer marker having a molecular weight of 1536 daltons
11/07/2002WO2002088717A2 Biopolymer marker having a molecular weight of 2056 daltons
11/07/2002WO2002088716A2 Polymer marker having a molecular weight of 1518 daltons
11/07/2002WO2002088715A2 Biopolymer marker having a molecular weight of 1465 daltons
11/07/2002WO2002088714A2 Individualization of therapy with antineoplastic agents
11/07/2002WO2002088713A2 Biopolymer marker having a molecular weight of 1521 daltons
11/07/2002WO2002088712A2 Biopolymer marker state having a molecular weight of 1777 daltons
11/07/2002WO2002088711A2 Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
11/07/2002WO2002088710A2 Biopolymer marker having a molecular weight of 2753 daltons
11/07/2002WO2002088709A2 Method for monitoring and validating stress induction of disease state
11/07/2002WO2002088708A2 Biopolymer marker having a molecular weight of 1077 daltons
11/07/2002WO2002088707A2 Biopolymer marker having a molecular weight of 1998 daltons
11/07/2002WO2002088706A2 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002WO2002088703A1 Automatic calibration mode for carbon dioxide sensor
11/07/2002WO2002088702A2 Dielelectrophoretic method and apparatus for high throughput screening
11/07/2002WO2002088696A1 Magnetic sensor and method for analysing a fluid
11/07/2002WO2002088691A2 Device and method for the quantitative determination of nitrogen oxides in exhaled air and application thereof
11/07/2002WO2002088686A1 Waveguide and assay
11/07/2002WO2002088681A1 Handy internal quality inspection instrument
11/07/2002WO2002088678A2 Portable apparatus for the non-destructive measurement of the internal quality of vegetable products
11/07/2002WO2002088665A2 Methods for identifying drugs specific for known molecular targets using model compounds specific for the molecular targets
11/07/2002WO2002088663A2 Hand-held automatic refractometer
11/07/2002WO2002088635A1 Significant signal extracting method, recording medium, and program
11/07/2002WO2002088534A1 Carbon dioxide sensor for controlling exhaust gas recirculation in diesel engines
11/07/2002WO2002088462A1 Process for controlling the temperature of a web and a device to use for said temperature control
11/07/2002WO2002088425A2 Determination of chloride corrosion threshold for metals embedded in cementitious material
11/07/2002WO2002088396A2 Reagents and methods for automated in situ or microarray hybridization
11/07/2002WO2002088384A1 Screening method
11/07/2002WO2002088383A2 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
11/07/2002WO2002088382A2 Method for analysing nucleic acid chains
11/07/2002WO2002088376A2 Multiple simultaneous antigen detection by immunohistochemistry
11/07/2002WO2002088349A1 Method of examining allergic disease using cathepsin-c alternative splicing form as indication
11/07/2002WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002WO2002088335A1 Stem cells and method of separating the same
11/07/2002WO2002088332A1 Small liver cell-rich colony, method of preparing the same, method of maturing the same into liver tissue and method of estimating drug function using the matured small liver cell-rich colony
11/07/2002WO2002088324A2 Methods for determining secondary modifications of molecules using arrays
11/07/2002WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088314A2 Ovary-specific genes and proteins
11/07/2002WO2002088309A2 Fusion genes associated with acute megakaryoblastic leukemias
11/07/2002WO2002088300A1 Use of a miniature device for separating and isolating biological objects and methods used
11/07/2002WO2002088299A1 Miniature device for separating and isolating biological objects and uses thereof
11/07/2002WO2002088296A1 Multichamber device and uses thereof for processing of biological samples
11/07/2002WO2002088189A2 Polysaccharide derivatives that can be photo-activated for immobilising bio-molecules
11/07/2002WO2002088185A2 Pan-specific monoclonal antibody
11/07/2002WO2002088181A2 Mrp8/mrp14 heterodimer, or its individual components in combination, for treating and/or preventing skin diseases, wounds and/or wound-healing disturbances
11/07/2002WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002WO2002088175A1 Crohn's disease antibody-binding peptide and method of examining crohn's disease
11/07/2002WO2002088174A2 Biopolymer marker having a molecular weight of 1865 daltons
11/07/2002WO2002088171A2 Combinatorial libraries of monomer domains
11/07/2002WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002WO2002088164A1 Human ox2 receptors
11/07/2002WO2002088160A1 Immobilization of oligonucleotides onto solid supports
11/07/2002WO2002087769A2 Method for parallel synthesis and transfer of molecules to a substrate
11/07/2002WO2002087632A1 High throughput screening methods using magnetic resonance imaging agents
11/07/2002WO2002087628A1 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin
11/07/2002WO2002087613A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002WO2002087609A1 Identification of a cell surface receptor for papillomaviruses
11/07/2002WO2002087608A1 Novel pain relievers which are trp-channel inhibitors
11/07/2002WO2002087554A2 Ef-tu binding agent as antibacterial agent
11/07/2002WO2002087551A1 A coated film laminate having an ionic surface
11/07/2002WO2002087530A1 Tyrosinase assay
11/07/2002WO2002087503A2 Compositions and methods for treating colorectal polyps and cancer
11/07/2002WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002WO2002087499A2 Cells for detection of enteroviruses
11/07/2002WO2002087417A2 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity
11/07/2002WO2002087306A2 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
11/07/2002WO2002075320A3 Liver function test
11/07/2002WO2002075316A9 Method of detecting amyloid-containing lesions by autofluorescence
11/07/2002WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002WO2002069890A3 Methods of identifying agents affecting atrophy and hypertrophy
11/07/2002WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002WO2002062950A3 Method for quantification of recombinant viruses
11/07/2002WO2002056751A3 Lancet device having capillary action
11/07/2002WO2002052016A3 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
11/07/2002WO2002046766A3 Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent
11/07/2002WO2002042492A3 Method for detecting protozoae of the genus naegleria
11/07/2002WO2002041870A3 Production and use of a targeted diagnostic system
11/07/2002WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002WO2002030967A3 Novel compounds
11/07/2002WO2002028897A3 Human g-protein coupled receptor and uses thereof
1 ... 2714 2715 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 ... 3937